355 related articles for article (PubMed ID: 20813765)
21. [Middle molecules removal. Beyond beta2-microglobulin].
Maduell F; Sánchez-Canel JJ; Blasco JA; Navarro V; Ríus A; Torregrosa E; Pin MT; Cruz C; Ferrero JA
Nefrologia; 2006; 26(4):469-75. PubMed ID: 17058859
[TBL] [Abstract][Full Text] [Related]
22. Pilot study to assess increased dialysis efficiency in patients with limited blood flow rates due to vascular access problems.
Mandolfo S; Borlandelli S; Imbasciati E; Badalamenti S; Graziani G; Sereni L; Varesani M; Wratten ML; Corsi A; Elli A
Hemodial Int; 2008 Jan; 12(1):55-61. PubMed ID: 18271842
[TBL] [Abstract][Full Text] [Related]
23. The dynamics of the metabolism of acetate and bicarbonate associated with use of hemodialysates in the ABChD trial: a phase IV, prospective, single center, single blind, randomized, cross-over, two week investigation.
Smith WB; Gibson S; Newman GE; Hendon KS; Askelson M; Zhao J; Hantash J; Flanagan B; Larkin JW; Usvyat LA; Thadhani RI; Maddux FW
BMC Nephrol; 2017 Aug; 18(1):273. PubMed ID: 28851317
[TBL] [Abstract][Full Text] [Related]
24. Intradialytic changes of serum magnesium and their relation to hypotensive episodes in hemodialysis patients on different dialysates.
Elsharkawy MM; Youssef AM; Zayoon MY
Hemodial Int; 2006 Oct; 10 Suppl 2():S16-23. PubMed ID: 17022745
[TBL] [Abstract][Full Text] [Related]
25. Haemodynamic consequences of changing bicarbonate and calcium concentrations in haemodialysis fluids.
Gabutti L; Bianchi G; Soldini D; Marone C; Burnier M
Nephrol Dial Transplant; 2009 Mar; 24(3):973-81. PubMed ID: 18842671
[TBL] [Abstract][Full Text] [Related]
26. In vivo removal of high- and low-molecular-weight compounds in hemodiafiltration with on-line regeneration of ultrafiltrate.
Testa A; Gentilhomme H; Le Carrer D; Orsonneau JL
Nephron Clin Pract; 2006; 104(1):c55-60. PubMed ID: 16741371
[TBL] [Abstract][Full Text] [Related]
27. [Hemodialysis with bicarbonate 30 mEq/l versus 34 mEq/l and acetate: better hemodynamic tolerance and electrolyte and acid-base homeostasis].
Bruges M; Barata JD; Oliveira C; Furstenau C; Gomes EM; Simões J
Acta Med Port; 1994 Mar; 7(3):165-70. PubMed ID: 8209702
[TBL] [Abstract][Full Text] [Related]
28. Comparison of haemodialysis (HD) and post dilution haemofiltration (HF) on an unselected dialysis population.
Baldamus CA; Schoeppe W; Koch KM
Proc Eur Dial Transplant Assoc; 1978; 15():228-35. PubMed ID: 740667
[TBL] [Abstract][Full Text] [Related]
29. [Acetate-free hemodialysis: what does it mean?].
Petitclerc T; Diab R; Le Roy F; Mercadal L; Hmida J
Nephrol Ther; 2011 Apr; 7(2):92-8. PubMed ID: 21130720
[TBL] [Abstract][Full Text] [Related]
30. Middle molecule accumulation in uremia: an "extra uremic factor".
Oulès R; Emond C; Claret G; Branger B; Mion H; Mion C
Artif Organs; 1981; 4 Suppl():177-83. PubMed ID: 7295089
[TBL] [Abstract][Full Text] [Related]
31. Protein-bound solute removal during extended multipass versus standard hemodialysis.
Eloot S; Van Biesen W; Axelsen M; Glorieux G; Pedersen RS; Heaf JG
BMC Nephrol; 2015 Apr; 16():57. PubMed ID: 25896788
[TBL] [Abstract][Full Text] [Related]
32. Short term study on relative merits of acetate and bicarbonate dialysis.
Gurudev KC; Pathak V; Prabhakar KS; Bhaskar S; Prakash KC; Prabhakaran ; Mani MK
J Assoc Physicians India; 1991 Dec; 39(12):921-4. PubMed ID: 1816218
[TBL] [Abstract][Full Text] [Related]
33. Influence of dialysate composition on cardiovascular function in isovolaemic haemodialysis.
Wehle B; Asaba H; Castenfors J; Gunnarsson B; Bergström J
Proc Eur Dial Transplant Assoc; 1981; 18():153-9. PubMed ID: 7329963
[TBL] [Abstract][Full Text] [Related]
34. Increasing the removal of protein-bound uremic toxins by liposome-supported hemodialysis.
Shi Y; Wang Y; Ma S; Liu T; Tian H; Zhu Q; Wang W; Li Y; Ding F
Artif Organs; 2019 May; 43(5):490-503. PubMed ID: 30375673
[TBL] [Abstract][Full Text] [Related]
35. Haemodialysis with on-line monitoring equipment: tools or toys?
Locatelli F; Buoncristiani U; Canaud B; Köhler H; Petitclerc T; Zucchelli P
Nephrol Dial Transplant; 2005 Jan; 20(1):22-33. PubMed ID: 15632348
[TBL] [Abstract][Full Text] [Related]
36. Uremic toxins: a new focus on an old subject.
Yavuz A; Tetta C; Ersoy FF; D'intini V; Ratanarat R; De Cal M; Bonello M; Bordoni V; Salvatori G; Andrikos E; Yakupoglu G; Levin NW; Ronco C
Semin Dial; 2005; 18(3):203-11. PubMed ID: 15934967
[TBL] [Abstract][Full Text] [Related]
37. Problems and solutions for artificial kidney.
Vanholder R
Technol Health Care; 2000; 8(6):373-9. PubMed ID: 11258583
[TBL] [Abstract][Full Text] [Related]
38. Dialysis therapy: 'think differently'.
Perrone B
Nephrol Dial Transplant; 2007 Jul; 22 Suppl 5():v1-2. PubMed ID: 17586840
[No Abstract] [Full Text] [Related]
39. Intradialytic removal of protein-bound uraemic toxins: role of solute characteristics and of dialyser membrane.
Lesaffer G; De Smet R; Lameire N; Dhondt A; Duym P; Vanholder R
Nephrol Dial Transplant; 2000 Jan; 15(1):50-7. PubMed ID: 10607767
[TBL] [Abstract][Full Text] [Related]
40. [Aspects of the on-line hemodiafiltration with regeneration and reinfusion of the ultrafiltrate (HFR): multicenter study].
De Simone W; De Simone M; De Simone A; Iannaccone S; Manganelli R; Zito B; Guastaferro P; Apperti V; Paglionico C; Salvati G; Veniero P; Ferro F; Tedesco V
G Ital Nefrol; 2004; 21 Suppl 30():S161-7. PubMed ID: 15750977
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
